Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02565381Completed
Randomised, open-label trial in Tobacco Use Disorder (TUD) (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Number of Participants With Biochemically-verified Smoking Abstinence at 8 weeks. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02565381.